place in Medical Technology
Navigation Links
place in Medical Technology
Community Leaders/Patients Encouraged to Discuss Challenges; Offer
Solutions
NEW YORK, Oct. 15 /PRNewswire-USNewswire/ -- On the heels of a major
report revealing that the vast majority of Americans -- and especially
women, older people and racial and ethnic minorities -- are either
under-re...
22 US Oncology Affiliated Physicians Participate in ASCO Proceedings HOUSTON, June 04, 2007 /PRNewswire/ -- A leading cancer researcher affiliated with the US Oncology Research Network presented findings from a randomized, multicenter phase III trial that compared the disease-free survival (DFS) o...
...-02 and MAESTRO-03 to determine our next steps," said Kevin Giese, President and CEO of BioMS Medical. "We are fortunate to have suitable resources in place to remain flexible to pursue whatever options emerge once we understand these results more fully." BioMS Medical Webcast Participants ma...
...Form 10-K for the year ended December 31, 2008 and its Quarterly Report on Form 10-Q for the period ended March 31, 2009. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update an...
...tial future indications or labeling for Tekturna or Tekturna HCT, or regarding potential future revenues from Tekturna or Tekturna HCT. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known...
...hrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or r...
...ent views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: tha...
...rward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, ...
...the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualifie...
... to present to the NIH, NCI's Clinical Center and the Center for Human Immunology, NERD (New Research and Development) Seminar Series, which will take place on Friday July 10, 2009 at the NIH's Clinical Center located at the main NIH campus, on 9000 Rockville Pike, Bethesda, MD. The title of Dr. Talor's p...
... of the potential harm that might befall the individual and his or her patients. Health care facilities should have written policies and procedures in place to assist when these highly emotionally charged situations involving health care providers occur, Dr. Berge and his colleagues write. Long-term recove...
...fornia Stem Cell (CSC) is preparing for a final FDA pre-IND meeting to take place in mid 2009. This is a critical step on the track to submitting a formal In...m Cell, Inc., "CSC is now preparing for a final FDA pre-IND meeting to take place in mid 2009, keeping us on track for a formal IND application to begin a Ph...
...g statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarif...
..."anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, bey...
...hrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or r...
...g statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarif...
...tion activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or re...
...ng potential new marketing approvals, or new indications or labeling for Afinitor or regarding potential future revenues from Afinitor. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known...
...l Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 30 - June 4, 2009 in Chicago, IL. The meeting presents approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI resear...
... for the year ended April 30, 2008 and the quarterly report on Form 10-Q for the quarter ended January 31, 2009. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does n...
...ssion, including its quarterly report on Form 10-Q for the quarter ended March 31, 2009, filed on May 11, 2009, with the SEC. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Medivation disclaims any obligation or undertaking ...
...opments relating to ChemoCentryx's competitors and other vagaries in the biotechnology industry and (xv) other risks. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their enti...
...l Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 30 - June 4, 2009 in Chicago, IL. The meeting presents approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI resear...
...al Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 31 - June 4, 2009, at McCormick place Convention Center, Chicago, IL. The meeting showcases approximately 5,000 ...
...ps were leukopenia, diarrhea, and peripheral edema. Four deaths, unrelated to treatment with Valcyte, occurred in the 100-day treatment group and took place in France, Belgium and Romania. They were attributed to hemorrhage (one), sepsis (one) or septic shock (two). About CMV CMV belongs to the ...
...ogical Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 30-June 4, 2009, at McCormick Place, Chicago, IL. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advan...
22 US Oncology Affiliated Physicians Participate in ASCO Proceedings HOUSTON, June 04, 2007 /PRNewswire/ -- A leading cancer researcher affiliated with the US Oncology Research Network presented findings from a randomized, multicenter phase III trial that compared the disease-free survival (DFS) o...
Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
.... Murphree. With preliminary testing complete, Dr. Murphree is currently developing a protocol for Phase I/II clinical trials in humans to take place over the coming year. Founded in 1928 with 12,000 members currently, ARVO is one of the nation's largest organizations for research in vision a...Pennsylvania Agriculture Department Issues Quarantine for Allegheny County Horse Stable
... "Equine Herpesvirus causes upper respiratory infection and can cause severe neurological disease in horses," said Wolff. "The quarantine was put in place to restrict the movement of horses from the stable and contain the virus." The quarantine covers the entire property, including five barns hous......-02 and MAESTRO-03 to determine our next steps," said Kevin Giese, President and CEO of BioMS Medical. "We are fortunate to have suitable resources in place to remain flexible to pursue whatever options emerge once we understand these results more fully." BioMS Medical Webcast Participants ma...
World's First Cardiac Adult Stem Cell Patient Receives Infusion
... Trial taking place in Louisville, KY LOUISVILLE, Ky., July 24 /PRNewswire-USNewswire/ -- Michael (Mike) Jones has become the world's first recipient of adult c......Form 10-K for the year ended December 31, 2008 and its Quarterly Report on Form 10-Q for the period ended March 31, 2009. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update an...
...tial future indications or labeling for Tekturna or Tekturna HCT, or regarding potential future revenues from Tekturna or Tekturna HCT. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known...
Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
...ult of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reas......hrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or r...
...ent views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: tha...
...rward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, ...
...the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualifie...
Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris
...ts, events or developments to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements. ...... to present to the NIH, NCI's Clinical Center and the Center for Human Immunology, NERD (New Research and Development) Seminar Series, which will take place on Friday July 10, 2009 at the NIH's Clinical Center located at the main NIH campus, on 9000 Rockville Pike, Bethesda, MD. The title of Dr. Talor's p...
... of the potential harm that might befall the individual and his or her patients. Health care facilities should have written policies and procedures in place to assist when these highly emotionally charged situations involving health care providers occur, Dr. Berge and his colleagues write. Long-term recove...
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
...ounds, and those detailed in the NovaBay's and Alcon's filings with the Securities and Exchange Commission. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except to the extent required under the federal securities laws and the rules and regulations pro...ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
...-MV-006) and 40 centres in Europe and North America (TG-MV-007). The safety review was the final of two safety reviews, and had been scheduled to take place after 50% of patients had been enrolled in one of the studies. The primary endpoint of both trials is the non-surgical resolution of focal vitr...Spherix Announces Positive Phase 2 Study Results
...tes treatments, continues to lead us to believe that there will likely be a place for Naturlose in the treatment regime as either a stand-alone or an adjunct...report on Form 8-K filed on October 10, 2007. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the...MADIT-CRT Trial Meets Primary Endpoint
...ual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. Factors that may cause such differences include, among other things: future economic, ...Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
...2009, by Dr R. Pfleger GmbH. In April 2009, Salvacyl(R) was also launched on a preliminary basis in Belgium. The effective commercial launch will take place in a couple of months. Salvacyl(R) contains the active substance triptorelin, a gonadotropin releasing hormone (GnRH) agonist analogue. The product wi...Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
... on Form 10-K for the year ended December 31, 2008, and our other public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their enti...Alfacell Provides Shareholder Update
...June 19 /PRNewswire-FirstCall/ -- Dear Shareholder, I am grateful to have this opportunity to share with you important developments taking place at this critical juncture in our company history. This communication shall mark what I hope will be the first of many as your president. Like ma......fornia Stem Cell (CSC) is preparing for a final FDA pre-IND meeting to take place in mid 2009. This is a critical step on the track to submitting a formal In...m Cell, Inc., "CSC is now preparing for a final FDA pre-IND meeting to take place in mid 2009, keeping us on track for a formal IND application to begin a Ph...
...g statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarif...
..."anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, bey...
New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform
...om a sick care system to a true health care system that stresses disease prevention." "Our country will never contain health care costs until we place a higher priority on public health and prevention programs, said Congresswoman Kay Granger (R-TX) Co-Chair of Prevention Caucus. "An investment of jus......hrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or r...
...g statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarif...
...tion activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or re...
...ng potential new marketing approvals, or new indications or labeling for Afinitor or regarding potential future revenues from Afinitor. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known...
...l Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 30 - June 4, 2009 in Chicago, IL. The meeting presents approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI resear...
... for the year ended April 30, 2008 and the quarterly report on Form 10-Q for the quarter ended January 31, 2009. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does n...
IBM and EU Partners Create a Better Way to Fight AIDS Virus
..., in 10 industry-related categories, to be honored at the Laureate Medal Ceremony. This year's ceremony and accompanying Gala Awards Evening will take place on June 1, 2009 at the Andrew W. Mellon Auditorium in Washington, D.C. The technology achievements honored by this program are preserved and prot......ssion, including its quarterly report on Form 10-Q for the quarter ended March 31, 2009, filed on May 11, 2009, with the SEC. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Medivation disclaims any obligation or undertaking ...
...opments relating to ChemoCentryx's competitors and other vagaries in the biotechnology industry and (xv) other risks. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their enti...
...l Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 30 - June 4, 2009 in Chicago, IL. The meeting presents approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI resear...
...al Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 31 - June 4, 2009, at McCormick place Convention Center, Chicago, IL. The meeting showcases approximately 5,000 ...
...ps were leukopenia, diarrhea, and peripheral edema. Four deaths, unrelated to treatment with Valcyte, occurred in the 100-day treatment group and took place in France, Belgium and Romania. They were attributed to hemorrhage (one), sepsis (one) or septic shock (two). About CMV CMV belongs to the ...
...ogical Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 30-June 4, 2009, at McCormick Place, Chicago, IL. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advan...
Other Tagsexposedhardhardhardhardlenslensflowflowflowflowflowbudbudbuddishdish
Breaking Biology News(10 mins):Understanding apples' ancestors 2Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference 13851 1NeoGenomics to Present at the Rodman 26 Renshaw Healthcare Investment Conference on September 10 2009 13849 1NeoGenomics to Present at the Rodman 26 Renshaw Healthcare Investment Conference on September 10 2009 13849 2HS 7 Document Regarding Research @ M D Anderson Orlando 4942 1
Breaking Medicine News(10 mins):Health News:Study shows how gene action may lead to diabetes prevention, cure 2Health News:HealthWyse Clinical and Financial Point of Care Software Addresses OASIS-C Regulations and More 2Health News:'Disease of Poverty': University of South Carolina Releases Journal on Cervical Cancer, Health Disparities 2Health News:'Disease of Poverty': University of South Carolina Releases Journal on Cervical Cancer, Health Disparities 3Health News:Baylor Hamilton Heart Hospital Honored for Innovative Rehabilitation Program 2Health News:Baylor Hamilton Heart Hospital Honored for Innovative Rehabilitation Program 3Health News:New Hope for Brain, Spinal Cord Injuries 2
Other Contentsetiologyetiologyetiologyexanthemexacerbateexacerbateexacerbateexacerbateexchangeexchangeexchangeexchangeexchangeexchangeexchangeexchangeexchangecryingcryingexcessiveexcessiveexcessiveexcessiveexcessiveexcessiveexcessiveexcessiveexciseexciseexciseexcise[0] Study shows how gene action may lead to diabetes prevention, cure[0] HealthWyse Clinical and Financial Point of Care Software Addresses OASIS-C Regulations and More [0] 'Disease of Poverty': University of South Carolina Releases Journal on Cervical Cancer, Health Disparities[0] Baylor Hamilton Heart Hospital Honored for Innovative Rehabilitation Program[0] New Hope for Brain, Spinal Cord Injuries
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |